Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a...

Area of Science:

• Infectious Diseases
• Immunology
• Orthopedic Surgery

Background:

• Prosthetic joint infection (PJI) is a severe complication of joint replacement surgery.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a common pathogen causing PJI.
• Staphylococcal virulence factors contribute to PJI pathogenesis.

Purpose of the Study:

• To evaluate the efficacy of AZD6389, a novel antibody combination, for prophylaxis against MRSA-PJI in a rabbit model.
• To assess the impact of targeting alpha-hemolysin, bicomponent cytotoxins, and clumping factor A on PJI outcomes.

Main Methods:

• A rabbit model of MRSA-PJI was established.
• Rabbits received prophylactic treatment with AZD6389 or control IgG.
• Clinical signs, bacterial burden in synovial tissue, and prosthetic implants were assessed.

Main Results:

• AZD6389 significantly reduced joint swelling, erythema, and intra-articular pus compared to controls.
• Prophylaxis with AZD6389 led to significant reductions in bacterial burden in synovial tissues and on implants.
• Biofilm-associated bacterial burden was notably decreased by the antibody treatment.

Conclusions:

• Targeting specific staphylococcal virulence factors with monoclonal antibodies is a promising strategy for PJI prevention.
• AZD6389 demonstrated significant efficacy in reducing the severity and bacterial load of MRSA-PJI in a preclinical model.
• This approach holds potential for clinical application in preventing prosthetic joint infections.